170 related articles for article (PubMed ID: 16412385)
1. Characterization of the two catalytic domains in histone deacetylase 6.
Zou H; Wu Y; Navre M; Sang BC
Biochem Biophys Res Commun; 2006 Mar; 341(1):45-50. PubMed ID: 16412385
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting the substrate specificity of histone deacetylases.
Riester D; Hildmann C; Grünewald S; Beckers T; Schwienhorst A
Biochem Biophys Res Commun; 2007 Jun; 357(2):439-45. PubMed ID: 17428445
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional studies of the yeast class II Hda1 histone deacetylase complex.
Lee JH; Maskos K; Huber R
J Mol Biol; 2009 Aug; 391(4):744-57. PubMed ID: 19573535
[TBL] [Abstract][Full Text] [Related]
4. Acetylation of histone deacetylase 6 by p300 attenuates its deacetylase activity.
Han Y; Jeong HM; Jin YH; Kim YJ; Jeong HG; Yeo CY; Lee KY
Biochem Biophys Res Commun; 2009 May; 383(1):88-92. PubMed ID: 19344692
[TBL] [Abstract][Full Text] [Related]
5. Toward an HDAC6 inhibitor: synthesis and conformational analysis of cyclic hexapeptide hydroxamic acid designed from alpha-tubulin sequence.
Jose B; Okamura S; Kato T; Nishino N; Sumida Y; Yoshida M
Bioorg Med Chem; 2004 Mar; 12(6):1351-6. PubMed ID: 15018907
[TBL] [Abstract][Full Text] [Related]
6. HDAC6 is a microtubule-associated deacetylase.
Hubbert C; Guardiola A; Shao R; Kawaguchi Y; Ito A; Nixon A; Yoshida M; Wang XF; Yao TP
Nature; 2002 May; 417(6887):455-8. PubMed ID: 12024216
[TBL] [Abstract][Full Text] [Related]
7. Regulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6.
Zilberman Y; Ballestrem C; Carramusa L; Mazitschek R; Khochbin S; Bershadsky A
J Cell Sci; 2009 Oct; 122(Pt 19):3531-41. PubMed ID: 19737819
[TBL] [Abstract][Full Text] [Related]
8. Substrate-assisted movement of the catalytic Lys 215 during domain closure: site-directed mutagenesis studies of human 3-phosphoglycerate kinase.
Flachner B; Varga A; Szabó J; Barna L; Hajdú I; Gyimesi G; Závodszky P; Vas M
Biochemistry; 2005 Dec; 44(51):16853-65. PubMed ID: 16363799
[TBL] [Abstract][Full Text] [Related]
9. Substrate and inhibitor specificity of class 1 and class 2 histone deacetylases.
Hildmann C; Wegener D; Riester D; Hempel R; Schober A; Merana J; Giurato L; Guccione S; Nielsen TK; Ficner R; Schwienhorst A
J Biotechnol; 2006 Jun; 124(1):258-70. PubMed ID: 16567013
[TBL] [Abstract][Full Text] [Related]
10. Members of the histone deacetylase superfamily differ in substrate specificity towards small synthetic substrates.
Riester D; Wegener D; Hildmann C; Schwienhorst A
Biochem Biophys Res Commun; 2004 Nov; 324(3):1116-23. PubMed ID: 15485670
[TBL] [Abstract][Full Text] [Related]
11. Characterization of human UDP-glucose dehydrogenase reveals critical catalytic roles for lysine 220 and aspartate 280.
Easley KE; Sommer BJ; Boanca G; Barycki JJ; Simpson MA
Biochemistry; 2007 Jan; 46(2):369-78. PubMed ID: 17209547
[TBL] [Abstract][Full Text] [Related]
12. The HDAC complex and cytoskeleton.
Kovacs JJ; Hubbert C; Yao TP
Novartis Found Symp; 2004; 259():170-7; discussion 178-81, 223-5. PubMed ID: 15171253
[TBL] [Abstract][Full Text] [Related]
13. HDAC6 α-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases.
Li G; Jiang H; Chang M; Xie H; Hu L
J Neurol Sci; 2011 May; 304(1-2):1-8. PubMed ID: 21377170
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of Ca(2+)/calmodulin-dependent protein kinase phosphatase (CaMKP).
Tada Y; Nimura T; Sueyoshi N; Ishida A; Shigeri Y; Kameshita I
Arch Biochem Biophys; 2006 Aug; 452(2):174-85. PubMed ID: 16844074
[TBL] [Abstract][Full Text] [Related]
15. Deactylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases.
Brush MH; Guardiola A; Connor JH; Yao TP; Shenolikar S
J Biol Chem; 2004 Feb; 279(9):7685-91. PubMed ID: 14670976
[TBL] [Abstract][Full Text] [Related]
16. Cloning, expression, and biochemical characterization of a new histone deacetylase-like protein from Thermus caldophilus GK24.
Song YM; Kim YS; Kim D; Lee DS; Kwon HJ
Biochem Biophys Res Commun; 2007 Sep; 361(1):55-61. PubMed ID: 17632079
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility to virus-cell fusion at the plasma membrane is reduced through expression of HIV gp41 cytoplasmic domains.
Malinowsky K; Luksza J; Dittmar MT
Virology; 2008 Jun; 376(1):69-78. PubMed ID: 18400243
[TBL] [Abstract][Full Text] [Related]
18. Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally.
Zhang Y; Kwon S; Yamaguchi T; Cubizolles F; Rousseaux S; Kneissel M; Cao C; Li N; Cheng HL; Chua K; Lombard D; Mizeracki A; Matthias G; Alt FW; Khochbin S; Matthias P
Mol Cell Biol; 2008 Mar; 28(5):1688-701. PubMed ID: 18180281
[TBL] [Abstract][Full Text] [Related]
19. Catalytic properties and kinetic mechanism of human recombinant Lys-9 histone H3 methyltransferase SUV39H1: participation of the chromodomain in enzymatic catalysis.
Chin HG; Patnaik D; Estève PO; Jacobsen SE; Pradhan S
Biochemistry; 2006 Mar; 45(10):3272-84. PubMed ID: 16519522
[TBL] [Abstract][Full Text] [Related]
20. A K52Q substitution in the globular domain of histone H1t modulates its nucleosome binding properties.
Ramesh S; Bharath MM; Chandra NR; Rao MR
FEBS Lett; 2006 Oct; 580(25):5999-6006. PubMed ID: 17052712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
